60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$0.89 -0.03 (-3.48%)
As of: Oct 21, 2026 · 3:58 PM EDT

60 Degrees Pharmaceuticals (SXTP) Finished Goods (2023 - 2025)

Updated

60 Degrees Pharmaceuticals' Finished Goods was $208,195 in Q2 2025, up 75.0% from $118,973 a year earlier and up 45.4% from the prior quarter.

Analysis

60 Degrees Pharmaceuticals (SXTP) Finished Goods (2023 - 2025) Analysis & Trends

At the end of FY2024, Finished Goods at 60 Degrees Pharmaceuticals came in at $157,881, down 15.7% from FY2023.

  • In earlier years, Finished Goods was $187,182 in FY2023.
  • Per Business Quant data, SXTP's Finished Goods in the three quarters before Q2 2025 was $143,161 (Q1 2025), $157,881 (Q4 2024) and $84,449 (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 60 Degrees Pharmaceuticals 2.37 Mn 1.35 Mn 56,798.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 208,195.00
Mar 31, 2025 143,161.00
Dec 31, 2024 157,881.00
Sep 30, 2024 84,449.00
Jun 30, 2024 118,973.00
Mar 31, 2024 156,390.00
Dec 31, 2023 187,182.00
API Access

60 Degrees Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=SXTP&period=max&api_key=YOUR_API_KEY